Business

Market OverviewThe Transthyretin amyloid cardiomyopathy (ATTR-CM) was valued at US$ 2.92 Billion n 2023. The global transthyretin amyloid cardiomyopathy (ATTR-CM)…

Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a…

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.If you have been diagnosed with transthyretin amyloid…

BackgroundCarpal tunnel syndrome (CTS) has been recognized as a potential early manifestation of systemic amyloidosis; however, its prognostic implications for…

AbstractBackground: Transthyretin (TTR) amyloid deposition in the tenosynovium in carpal tunnel syndrome (CTS) is a potential early manifestation of systemic…

DUBLIN--(BUSINESS WIRE)-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics…

− Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared…

AbstractBackgroundMost intracerebral hemorrhages (ICH) are caused by 1 of 2 cerebral small vessel diseases (cSVDs): arteriolosclerosis and cerebral amyloid…

Carol Boyers' carpal tunnel history raised some red flags for her doctor. After three surgeries on her right hand, he suggested a biopsy.“Just a small little…

NEW YORK—In 2002, Don Brockman was diagnosed with amyloidosis. The following year, he and his wife launched the nonprofit Amyloidosis Foundation, and in 2007,…